Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder, Overactive

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

602 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00689104

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Auchenflower, Australia

Clayton, Australia

Kogarah, Australia

Randwick, Australia

View all 218 locations

View Trial Details

Completed

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

NCT04562090

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +13 more
Locations: Site CN86020 Wuhan, Hubei, China

Site CN86001 Beijing, China

Site CN86004 Beijing, China

Site CN86014 Beijing, China

View all 15 locations

View Trial Details

Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076

NCT01655069

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations: Site: 1006 Shreveport, Louisiana, United States

Site: 3202 Antwerp, Belgium

Site: 3209 Antwerp, Belgium

Site: 3208 Charleroi, Belgium

View all 39 locations

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

NCT02757768

Conditions: Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Site US01009 Homewood, Alabama, United States

Site US01005 Huntsville, Alabama, United States

Site US01012 Anchorage, Alaska, United States

Site US01070 Hawaiian Gardens, California, United States

View all 79 locations

View Trial Details

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

NCT02656173

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations: Site JP81046 Aichi, Japan

Site JP81009 Chiba, Japan

Site JP81045 Chiba, Japan

Site JP81041 Fukuoka, Japan

View all 58 locations

View Trial Details

Completed

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

NCT01747577

Conditions: Benign Prostate Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Seoul, South Korea

View Trial Details

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01604928

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Site: 12 Brussels, Belgium

Site: 13 Edegem, Belgium

Site: 11 Ghent, Belgium

Site: 10 Leuven, Belgium

View all 30 locations

View Trial Details

Completed

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Chūbu, Japan

Kantou, Japan

Kinki, Japan

Kyushu, Japan

View Trial Details

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

NCT00527033

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations: Chūbu, Japan

Hokkaido, Japan

Kansai, Japan

Kanto, Japan

View Trial Details

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Beijing, China

Dalian, China

Fuzhou, China

Guangzhou, China

View all 35 locations

View Trial Details